| Lizenz: Creative Commons Namensnennung 4.0 International (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-384044
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.38404
Zusammenfassung
BackgroundThe sensitivity of estrogen receptor-positive breast cancers to tamoxifen treatment varies considerably, and the molecular mechanisms affecting the response rates are manifold. The human epidermal growth factor receptor-related receptor HER2 is known to trigger intracellular signaling cascades that modulate the activity of coregulators of the estrogen receptor which, in turn, reduces ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik